Go to the list of all blogs
published in Blogs
Aug 10, 2026
e.l.f. Beauty (ELF) Eyes $120 Target With +22% Upside Potential

e.l.f. Beauty (ELF) Eyes $120 Target With +22% Upside Potential

Key Takeaways

  • e.l.f. Beauty (NYSE: ELF) trades near $98.50, and the $120 price target represents approximately 22% upside from current levels.
  • The strongest bullish catalysts include rapid growth from the Rhode skincare acquisition, the newly launched e.l.f. Hair product line, and expanding international distribution.
  • The biggest obstacle is slowing growth in the core e.l.f. Cosmetics brand, which has faced unit-volume pressure following price increases and softer innovation performance.
  • Key support rests near $85–$90, while resistance sits at the psychologically important $100 level and the analyst cluster between $110 and $120.
  • Reaching $120 is realistic if Rhode and hair care momentum continues and the core brand stabilizes, but the stock will need sustained execution across multiple fronts to get there.

Why the $120 Level Matters

After a dramatic round-trip from $150.99 to $48.82 and back toward $98, ELF has become one of the most closely watched consumer stocks in the market. The $120 level sits at a natural intersection: it is well above the current price yet still within the range of Wall Street analyst targets, and it represents a round psychological marker that frequently attracts attention from traders and institutional investors alike. For a stock that has delivered 30 consecutive quarters of net sales growth, the question is not whether the business is growing — it is whether that growth can re-accelerate enough to justify a move back toward the upper end of its valuation range.

Where ELF Stands Today

e.l.f. Beauty, headquartered in Oakland, California, has transformed from a single-brand budget cosmetics company into a multi-brand beauty platform. Its portfolio now includes e.l.f. Cosmetics, e.l.f. Skin, Naturium, Well People, and the recently acquired Rhode skincare brand. The company reported fiscal first-quarter 2027 net sales of approximately $479 million, representing 36% year-over-year growth, and raised its full-year revenue guidance to $1.94–$1.97 billion. Shares have rallied roughly 40% since the May 2026 lows, yet the stock remains well below its 52-week high of $150.99, reflecting persistent investor caution around the core brand's trajectory and broader tariff-related uncertainty affecting Chinese-manufactured goods.

Catalysts That Could Push ELF Toward $120

The Rhode acquisition, completed in August 2025 for approximately $1 billion, has emerged as the company's most powerful growth engine. Rhode delivered roughly $390 million in net sales during fiscal 2026 and has been described by management as the most successful brand launch in Sephora's history across North America. International expansion continues, with Rhode now rolling out across Sephora locations in 19 European countries. The brand's unaided consumer awareness remains in the single digits, suggesting a long runway for growth as marketing investment builds recognition.

The newly launched e.l.f. Hair category represents another potential catalyst. Early sell-through data has been strong, with the Gloss Mode Treatment Oil selling out at Target within weeks of launch and social media sentiment running five to seven times above the average new brand introduction. Analysts at Canaccord Genuity estimate the hair care line could reach at least $200 million in annual sales. Bernstein upgraded ELF to Outperform with a $113 price target, explicitly citing hair care as a growth driver comparable to the company's earlier successful expansion into skincare.

Additionally, approximately $50 million in tariff refunds — following a Supreme Court ruling that invalidated certain import duties — provides a one-time financial cushion that management plans to reinvest into marketing and international expansion. These funds could amplify growth in the near term without requiring additional balance sheet leverage. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Risks That Could Hold the Stock Back

The core e.l.f. Cosmetics brand remains the largest concern. Organic core brand sales declined in the high single digits during the most recent quarter when excluding the Rhode contribution. A $1 portfolio-wide price increase implemented in August 2025 to offset tariff costs dampened unit volumes more than anticipated, and spring 2026 product innovation underperformed historical benchmarks. Management is now selectively reducing prices on certain items — the Halo Glow skin tint cut from $18 to $14 generated a 38–60% unit lift in testing — but a broader recovery in the core brand is not yet confirmed.

Tariff exposure is another material risk. Approximately 75% of e.l.f.'s production originates in China, making the company sensitive to shifts in trade policy. While tariff rates have moderated from roughly 55% to approximately 35%, sustained or escalating trade tension could pressure margins and force additional pricing decisions that conflict with the brand's value positioning. The company's balance sheet also carries elevated debt following the Rhode acquisition, with a net debt-to-EBITDA ratio near 2x, limiting financial flexibility if growth disappoints.

Analyst Views and Price Targets

Wall Street consensus on ELF remains predominantly bullish, with roughly 71% of covering analysts rating the stock a Buy and no firms carrying a Sell rating. However, price targets vary widely, reflecting genuine uncertainty about the pace of recovery. B. Riley Securities holds the Street-high target at $150, while more cautious firms such as Piper Sandler maintain targets closer to $50–$65. The average analyst target sits near $85–$90, though several firms — including Bernstein ($113), Jefferies ($115–$121), and Truist ($130) — have targets that bracket or exceed the $120 level. The dispersion in estimates underscores a core tension: the bull case depends on portfolio diversification succeeding, while the bear case argues that the core brand slowdown may prove structural rather than temporary.

Technical Levels Worth Watching

From a technical perspective, ELF is approaching a meaningful test of the $100 psychological resistance level, which also roughly coincides with the stock's 200-day moving average near $76–$80 in recent weeks — though the moving average has been rising as the stock recovers. A sustained break above $100 would place the next major resistance zone between $110 and $120, an area that aligns with multiple analyst price targets and the stock's pre-downtrend consolidation zone from late 2025. On the downside, support has built near $85–$90, where buyers stepped in repeatedly during July and early August 2026. The $48.82 level, representing the May 2026 trough, serves as the longer-term downside anchor.

AI Daily Buy/Sell Signals

In my research process, I turn to Tickeron’s AI Daily Buy/Sell Signals to monitor fast-moving names like this one. The tool applies artificial intelligence across thousands of stocks and ETFs to generate real-time Buy, Sell, or Hold signals based on technical patterns, trends, and broader market dynamics. It helps surface potential shifts early, which is useful when evaluating whether a recovery can hold and extend toward higher targets such as $120.

Final Assessment

The $120 price target for e.l.f. Beauty is ambitious but grounded in observable business momentum. Rhode's blistering growth, the promising hair care launch, international retail expansion, and improving tariff conditions all provide legitimate pathways for the stock to continue its recovery. However, reaching $120 will almost certainly require the core e.l.f. Cosmetics brand to return to positive organic growth, as no amount of acquisition-driven expansion can fully compensate for sustained weakness in the brand that still generates the majority of company revenue. Investors should monitor consumption data from Nielsen, the pace of international Rhode rollout, early hair care sales trends, and any shifts in trade policy — these variables will collectively determine whether ELF can break through the $100 ceiling and sustain a move toward $120 and beyond.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ELF

ELF sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for ELF moved above the 200-day moving average on August 17, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ELF advanced for three days, in of 325 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 280 cases where ELF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ELF moved out of overbought territory on September 01, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 51 similar instances where the indicator moved out of overbought territory. In of the 51 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where ELF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on September 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ELF as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ELF turned negative on September 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ELF broke above its upper Bollinger Band on August 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ELF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.833) is normal, around the industry mean (17.803). P/E Ratio (97.714) is within average values for comparable stocks, (45.187). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.665). ELF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.035). P/S Ratio (3.253) is also within normal values, averaging (1.918).

Notable companies

The most notable companies in this group are Procter & Gamble Company (NYSE:PG), Colgate-Palmolive Company (NYSE:CL).

Industry description

Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.

Market Cap

The average market capitalization across the Household/Personal Care Industry is 22.44B. The market cap for tickers in the group ranges from 81.32K to 332.07B. PG holds the highest valuation in this group at 332.07B. The lowest valued company is QNTA at 81.32K.

High and low price notable news

The average weekly price growth across all stocks in the Household/Personal Care Industry was -6%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 4%. ODD experienced the highest price growth at 13%, while TANH experienced the biggest fall at -98%.

Volume

The average weekly volume growth across all stocks in the Household/Personal Care Industry was 20%. For the same stocks of the Industry, the average monthly volume growth was 18% and the average quarterly volume growth was 7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 49
Price Growth Rating: 59
SMR Rating: 72
Profit Risk Rating: 91
Seasonality Score: -54 (-100 ... +100)
View a ticker or compare two or three
ELF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a holding company

Industry HouseholdPersonalCare

Profile
Details
Industry
Household Or Personal Care
Address
601 12th Street
Phone
+1 510 778-7787
Employees
849
Web
https://www.elfcosmetics.com
Interact to see
Advertisement
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.
RAIL shares fell approximately 15% in premarket trading on March 10, 2026, following a steep after-hours reaction to disappointing Q4 2025 earnings results released after the close on March 9. The primary catalyst was a significant revenue miss: Q4 revenue came in at $125.6 million, well below consensus estimates near $144–$160 million, representing an 8.8% year-over-year decline.
ZVRA shares surged approximately +17.86% on March 10, 2026, driven by a blockbuster Q4 and full-year 2025 earnings report released before the market open. Primary catalyst: Q4 2025 EPS of $0.19 crushed the consensus estimate of $0.05 — a 280% beat — while revenue of $34.1 million exceeded forecasts by 21.57%.
LITE surged +14.73% on Monday, March 9, 2026, closing at $640.69 versus a prior close of $558.44 on March 6. The primary catalyst was the landmark $2 billion strategic investment by NVIDIA announced March 2, with the market continuing to price in its full implications following a brief post-announcement pullback.
Shares of BNTX fell approximately 22% on Tuesday, March 10, 2026, following a dual shock of disappointing full-year guidance and a surprise leadership upheaval. The primary catalyst was BioNTech's Q4 2025 earnings report, which included a 2026 revenue outlook of €2.0–€2.3 billion — well below analyst consensus and signaling continued pressure from declining COVID-19 vaccine demand.
CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.
Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.
Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.